| Novelix Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 536565 |
NSE Symbol : - |
P/E(TTM) : 113.60 |
|
ISIN Demat : INE314I01036 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.55 |
|
Book Value(₹) : 18.10 |
Market Cap(₹Cr) : 110.06 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 36.36 | 22.35 | 20.86 | 5.30 | 3.96 | 0.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 36.36 | 22.35 | 20.86 | 5.30 | 3.96 | 0.60 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.03 | 0.00 | 0.00 | 0.00 | -0.08 | 0.10 |
| Total Income | 36.39 | 22.35 | 20.86 | 5.30 | 3.87 | 0.70 |
| Total Expenditure | 35.66 | 22.17 | 20.63 | 5.17 | 3.74 | 1.04 |
| PBIDT | 0.73 | 0.18 | 0.23 | 0.13 | 0.14 | -0.34 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.73 | 0.18 | 0.23 | 0.13 | 0.14 | -0.34 |
| Depreciation | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 |
| Tax | 0.18 | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.01 | 0.03 | 0.00 | -0.02 | 0.00 | 0.01 |
| Reported Profit After Tax | 0.53 | 0.11 | 0.18 | 0.15 | 0.13 | -0.35 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.53 | 0.11 | 0.18 | 0.15 | 0.13 | -0.35 |
| EPS (Unit Curr.) | 0.37 | 0.09 | 0.18 | 0.15 | 0.16 | -0.43 |
| EPS (Adj) (Unit Curr.) | 0.37 | 0.09 | 0.18 | 0.15 | 0.16 | -0.43 |
| Calculated EPS (Unit Curr.) | 0.37 | 0.11 | 0.18 | 0.15 | 0.13 | -0.44 |
| Calculated EPS (Adj) (Unit Curr.) | 0.37 | 0.11 | 0.18 | 0.15 | 0.13 | -0.44 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.47 | 0.43 | 0.73 | 0.59 | 0.52 | -1.75 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.47 | 0.43 | 0.73 | 0.59 | 0.52 | -1.75 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 14.48 | 9.95 | 9.95 | 9.95 | 9.95 | 8.10 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.01 | 0.81 | 1.10 | 2.45 | 3.54 | -56.67 |
| PBDTM(%) | 2.01 | 0.81 | 1.10 | 2.45 | 3.54 | -56.67 |
| PATM(%) | 1.46 | 0.49 | 0.86 | 2.83 | 3.28 | -58.33 |